UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities and Exchange Act of 1934

Date of Report (Date of earliest event reported) November 12, 2018

 

 

SUNLINK HEALTH SYSTEMS, INC.

(Exact Name Of Registrant As Specified In Charter)

 

 

 

Ohio		1-12607		31-0621189
(State or other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)
900 Circle 75 Parkway, Suite 1120, Atlanta, Georgia				30339
(Address of principal executive offices)				(Zip Code)

Registrant’s telephone number, including area code (770) 933-7000

 

 

(Former Name Or Former Address, If Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A-2. below:

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 5.07

Submission of Matters to a Vote of Security Holders

The following matters were submitted to a vote of common shareholders at the 2018 annual meeting of stockholders of SunLink Health Systems, Inc. (the “Company”) held on November 11, 2018:

Election of Directors

Management’s nominees for election to the board of directors, as listed in the Company’s proxy statement, were elected for two-year terms; with the results of the voting as follows:

 

Nominee		For				Withheld				Against		Broker Non-Votes
C. Michael Ford			2,750,274				268,258			0			3,271,136
Christopher H. B. Mills			2,630,678				387,854			0			3,271,136
Howard E. Turner			2,750,272				268,260			0			3,271,136

As indicated in the table above, C. Michael Ford, Christopher H. B. Mills and Howard E. Turner were elected as directors for terms expiring at the 2020 annual meeting of shareholders. Karen B, Brenner, whose current term of directorship ended at the 2018 annual meeting, did not stand for re-election at the annual meeting of 2018. The terms of the following incumbent directors continue until the 2019 annual meeting of shareholders: Robert M. Thornton, Jr., Dr, Steven J. Baileys and Gene E. Burleson.

Management also proposed the ratification of the appointment of the Company’s independent auditors for the 2019 fiscal year. The table below summarizes the results of the voting on these proposals by the Company’s stockholders:

Ratification of the appointment of Cherry Bekaert LLP as the Company’s Independent Registered Public Accounting Firm.

 

For		Against		Abstentions
6,216,639		426		72,603

As indicated in the above table, the proposal to ratify the appointment of the Company’s independent auditors for the 2019 fiscal year was approved.

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 14, 2018

 

 

3